﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://cubicin.legalview.com/msn/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-antibiotic-programs-featured-in-47-presentation/1236144/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-to-host-product-pipeline-investor-and-analyst-e/1236143/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-to-add-100-jobs/1236142/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharma-promotes-steven-gilman-to-evp-research-and-development-a/1236141/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-antibiotic-programs-featured-in-47-presentation/1236140/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-to-host-product-pipeline-investor-and-analyst-e/1236139/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-announces-promotion-of-steven-c-gilman-phd-to-e/1236138/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-expanding-in-lexington-adding-jobs/1236137/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-prepares-for-continued-growth/1236136/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-to-present-at-september-investor-conferences/1236135/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-antibiotic-programs-featured-in-47-presentation/1236134/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharma-to-oppose-tevas-move-to-amend-answer-in-patent-litigatio/1198187/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-to-oppose-tevas-attempt-to-add-inequitable-cond/1198186/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/trius-moves-antibiotic-toward-next-trial-as-deficit-rises/1198185/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/polymedix-successfully-completes-phase-1b-clinical/1160002/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-to-end-development-of-cb-500929/1160001/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/wwwstockmarketinginccom-tuesdays-pick-gsae-green-star/1132477/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/what-we-like-about-cubist-pharma/1132476/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-calls-surge-with-buyout-rumors/1132475/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-inc-pharmaceuticals-healthcare-deals/1132474/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/the-boston-globe-names-cubist-to-globe-100s-top-places-to-work-09/1132473/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-nearly-doubles-quarterly-revenue-in-a-year/1110441/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharma-files-patent-infringement-lawsuit-against-teva-update/1110440/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-files-ip-lawsuit-against-teva/1110439/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/daptomycin-in-experimental-murine-pneumococcal-meningitis/1110438/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/the-cure-no-one-saw/1110437/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/inserting-and-replacing-cubist-pharmaceuticals-to-present-at-june-2009/1110436/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-2-nd-quarter-total-net-revenues-up-28/1110435/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/3-small-cap-stocks-the-pros-like/1110434/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-initiates-phase-2-trial-in-europe-for-therapy/1110433/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharma-swings-to-a-profit/1110432/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/update-1-cubist-q2-profit-tops-street/1110431/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-and-forma-therapeutics-form-a-multi-million-dollar-deal/1110430/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/analyst-upgrades-downgrades-and-initiations-axp-fcx-fig-jpm-lyg/1110429/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://cubicin.legalview.com/msn/cubist-pharmaceuticals-and-the-new-england-patriots-radio-network-team/1110428/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
